Technology developments and applications by unknown
ABSTRACTS
Technology developments and applications
 Human Genome Organisation (HUGO) International Limited 2009
064: Keeping pace with the innovation: An easily
adaptable technique for rapidly generating humanized
animal models in the era of human genome
Subeer S. Majumdar, Suveera Dhup, Abul Usmani,
Mukkesh Gautam, Indrashis Bhattacharya
National Institute of Immunology, Aruna asaf ali marg,
New Delhi 110067, India
The phenomenal increase in the amount of information about human
genome is having a huge impact on biomedical research. Transgenic
mice have become invaluable resource and it serves as the most
powerful tool for analysing gene function and regulation in vivo.
Through research utilizing the transgenic mouse or non-human pri-
mate as a model for human disease, investigators can translate basic
biological phenomena into a human health perspective. A rapid
procedure for making transgenic mice is also needed for screening
thousands of human genes whose functions are yet unknown.
Pronuclear DNA microinjection in the oocyte is the most fre-
quently used technique for generating transgenic animals. This and
other techniques for making transgenic animals are fairly compli-
cated, requiring trained personnel, costly infrastructure and a large
number of zygotes harvested from animals that are then killed. Due to
technical difficulties in obtaining substantial number of embryos from
non-human primates and limitations in repeated surgical intervention
in them, it is practically difficult to make much needed models of
transgenic primates necessary to study several diseases specific to
primates. All these drawbacks generate a need for developing a handy
and cost effective technique for producing transgenic animals pref-
erably with minimum or no loss of animal lives. We have developed a
reproducible non-terminal technique for inserting genes in testicular
spermatogonial cells through in vivo electroporation of the testis. The
optimal result was obtained by injecting linearized DNA into the
testis of male mice, followed by electroporation using 82 40 V electric
pulses in alternating direction with a time constant of 0.05 s and an
inter pulse interval of *1 s. The transgenesis was confirmed by PCR,
Southern blot analysis and immunohistochemical studies of the
progeny. More than 90% of males electroporated with any one of the
four different constructs successfully sired transgenic pups. Such
electroporated males provide a valuable resource for continuous
production of transgenic founders. This method requires neither
assisted reproductive techniques nor sophisticated laboratory setup
and highly trained personnel. This ethically superior (deathless) and
easily adaptable time saving procedure opens avenues for developing
several transgenic mice in short span of time and broadens the scope
of making transgenic sub-human primates. (This study was funded by
Department of Biotechnology, India.)
065: Human whole genome sequencing by
high-throughput, short read oligonucleotide ligation
1F. C. L. Hyland, 1F. M. De La Vega, 2H. E. Peckham, 2S. S. Ranade,
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2C. R. Clouser, 2A. A. Antipova, 2J. M. Manning, 2C. L. Hendrickson,
2L. Zhang, 2E. T. Dimalanta, 2T. D. Sokolsky, 2M. W. Laptewicz,
2B. E. Coleman, 2J. K. Ichikawa, 2J. B. Warner, 1B. Li, 3A. Bashir,
3V. Bansal, 3V. Bafna, 2G. L. Costa, 2K. J. McKernan
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The advent of new ultra-high throughput sequencing methods allows
contemplation of resequencing thousands of human genomes to
extensively survey common and rare forms of genetic variation that
could have implications in health and disease. We sequenced the
genome of an individual of African origin with the Applied Biosys-
tems SOLiDTM system. The method allows sequencing of single or
paired ends 25–50 bp reads of 108–109 templates on a single array
containing beads with clonally amplified templates. We collected
over a billion reads in seven runs, amounting to a total of 32 Gbp of
sequence, and obtained an average 12X haploid sequence coverage
and 130X clone coverage. After aligning those reads to the hg18
reference assembly, over 95% of the genome is covered and 99.45%
of the genome is spanned by a paired end clone. A novel error cor-
rection technique improves the accuracy of the aligned reads to
[99.95%. With such accuracy, our results suggest that heterozygote
identification can be efficiently achieved at 10–15X coverage levels,
by comparison with known HapMap genotypes. We detected over
2 million SNPs, of which 81.4% are in dbSNP. We categorize the
genes using the Panther ontology, and annotate the damaging
potential of non-synonymous SNPs using PolyPhen. We discovered
that transcription factors, ligases, growth factors, receptors, and RNA
helicases are the molecular functions most under-represented for
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damaging mutations, and GPCR genes involved in Olfaction, and
genes for Immunity and defense are the biological functions most
over-represented for damaging mutations. Olfaction and Immunity
have previously been observed to be under recent positive selection in
human populations; thus we recapitulate evidence of natural selection
in a single human sample. 90,000 small insertions and deletions
(\12 bp) were identified with the use of paired end reads. Indels are
significantly underrepresented in translated exons. The analysis of the
distance and orientation of the paired end reads allowed the identi-
fication of thousands of putative insertions and deletions ranging from
50 bp to several Kb. We predict 50 inversions (25% previously
reported in other samples) and 4 gene fusions resulting from deletions
(two previously reported). Depth of coverage analysis allows the
inference of copy-number variants. Our results provide guidance for
future studies to discover sequence and structural variants in human
populations and cancer with short-read next generation sequencing.
066: Replacing PCR with COLD-PCR enriches
variant DNA sequences and redefines the sensitivity
of genetic testing
Mike Makrigiorgos, Jin Li, Lilin Wang, Harvey Mamon,
Matthew Kulke, Ross Berbeco
Dana Farber Cancer Institute, Harvad Med School, 44 Binney Street,
Boston MA 0215, USA
The Polymerase Chain Reaction (PCR) has become the cornerstone of
molecular diagnosis, with almost every genetic test aiming to identify
DNA sequence variation incorporating PCR. A commonly encountered
problem is that variant DNA sequences exist in the presence of a large
majority of wild type alleles such as when DNA is obtained from
heterogeneous cancer biopsies or when fetal alleles are sought in
maternal blood. As a result, downstream assays are severely limited in
their ability to identify subtle genetic changes that can have profound
impact in clinical decision-making and outcome. We describe Co-
amplification at Lower Denaturation temperature (COLD-PCR), a
novel form of PCR that amplifies minority alleles selectively from
mixtures of wild-type and mutation-containing sequences irrespective
of the mutation type or position on the sequence (Technical Report,
Nature Medicine, May 2008 issue). In COLD-PCR, an intermediate
annealing temperature is used during PCR-cycling to allow cross-
hybridization of mutant and wild type alleles; hetero-duplexes, which
melt at lower temperatures than homo-duplexes, are then selectively
denatured and amplified at Critical Denaturation Temperature (Tc),
while homo-duplexes remain double-stranded and do not amplify
efficiently. To validate COLD-PCR, we used serial dilutions of DNA
from tumor-derived cell lines and genomic DNA from a series of colon
and lung cancer surgical specimens, and plasma-circulating DNA
collected under IRB approval were utilized for validation on clinical
specimens. By replacing regular PCR with COLD-PCR prior to
application of a range of assays (Sanger sequencing; Pyrosequencing;
MALDI-TOF; dHPLC; RFLP; and Taqman) we improved mutation
detection sensitivity up to 100-fold and identified several additional
TP53/KRAS/EGFR mutations in heterogeneous cancer samples. About
4 of 43 surgical samples and 3 of 10 plasma samples tested contained
clinically important mutations that were not detected by any of the
methods tested when preceded by regular-PCR, but they were detect-
able following COLD-PCR. Replacement of regular PCR with COLD-
PCR provides a universal boost to all mutation detection technologies
and enables them to be used with the required confidence in routine
screening of cancer specimens for somatic mutations, including low-
level mutation screening of surgical/FFPE tumor samples or bodily
fluids. COLD-PCR is equally applicable to fields other than cancer,
such as pre-natal diagnosis, in infectious diseases and in epigenetics.
067: Characterization of whole blood gene expression
profiles in sickle cell disease with enhanced transcript
detection using globin mRNA reduction
1Nalini Raghavachari, 1Xiuli Xu, 2Peter Munson, 3Mark Gladwin
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Room temperature whole blood mRNA stabilization procedures, such
as the PAX gene system, are critical for the application of transcrip-
tional analysis to population based clinical studies. Global tran-
scriptome analysis of whole blood RNA using microarrays has been
proven to be challenging due to the high abundance of globin transcripts
that constitute 70% of whole blood mRNA in the blood. This is a
particular problem in patients with sickle cell disease, secondary to the
high abundance of globin-expressing nucleated red blood cells and
reticulocytes in the circulation. In order to more accurately measure the
steady state whole blood transcriptome in sickle cell patients we eval-
uated the efficacy of reducing globin transcripts in paxgene stabilized
RNA samples for genome-wide transcriptome analyses using oligonu-
cleotide arrays. We demonstrate here by both microarrays and Q-PCR
that the globin mRNA depletion method resulted in 55- to 65-fold
reduction in globin transcripts in whole blood collected from healthy
volunteers and sickle cell disease patients. This led to a dramatic
improvement in microarray data quality with increased detection rate of
expressed genes and improved overlap with the expression signatures of
isolated peripheral blood mononuclear (PBMC) preparations. The dif-
ferentially modulated genes from the globin depleted samples had a
higher correlation coefficient to the 116 genes identified to be signifi-
cantly altered in our previous study on sickle cell disease using PBMC
preparations. Additionally, the analysis of differences between the
whole blood transcriptome and PBMC transcriptome reveals important
erythrocyte genes that participate in sickle cell pathogenesis and com-
pensation. The combination of globin mRNA reduction after whole-
blood RNA stabilization represents a robust clinical research method-
ology for the discovery of biomarkers for hematologic diseases and in
multicenter clinical trials investigating a wide range of nonhematologic
disorders where fractionation of cell types is impracticable.
068: Evaluation of factors affecting the success
of multiplex PCR
Lauris Kaplinski, Maido Remm
Institute of Molecular and Cell Biology, University of Tartu, Riia 23,
Tartu 51010, Estonia
A set of 200 genomic PCR primers was tested in multiplex experi-
ments. All primers were working flawlessly in single-plex
experiments, as determined by gel electrophoresis. In multiplex
environment about 5% of 2-plex experiments and 25% of 4-plex
experiments failed to produce at least one of expected PCR products.
By using statistical model we determined the factors that have cor-
relation with the degradation of the quality of multiplex PCR. The
most important factor was the number of possible alternate genomic
binding sites of primers, as determined by nearest-neighbour ther-
modynamic model. The same factor is also correlated with the
degradation of the quality of single-plex PCR, but the effect is much
stronger in multiplex conditions. We also found, that the hybridiza-
tion affinity between primers of different PCR, calculated by nearest-
neighbour thermodynamic model, is correlated with the degradation
of the quality of multiplex PCR, although the effect is much lower
than the effect of genomic hybridization. These results can be used in
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the design process of primers for multiplex PCR. Lower quality
primers can be eliminated already in design phase. Additional testing
for unwanted hybridization between different PCR primer pairs can
be used as criterion in designing multiplex groups.
069: A new assay in functional genomics: Monitoring
cell differentiation in live cell chips by electric
cell-substrate impedance sensing
1,2Christian Maercker, 3Dirk Breitkreutz, 4Armin Bieser,
5Karen Bieback, 2Michael Angstmann
1German Cancer Research Center, Core Facilities Genomics and
Proteomics, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany,
2Mannheim University of Applied Sciences, Paul Wittsack Strasse 10,
68163 Mannheim, Germany, 3German Cancer Research Center,
Heidelberg, Germany, 4ibidi GmbH, Martinsried, Germany,
5Institute for Transfusion Medicine and Immunology,
University of Heidelberg, Mannheim, Germany
There is a great demand for cell-based in vitro screening systems for
drug target validation and generation of resources for cell therapies.
Our assay is focused on the formation of contacts between cells and
between cells and the extracellular matrix, which is important for cell
differentiation processes relevant in cancer therapy and tissue repair.
Cellular interactions are measured with a method called electric cell-
substrate impedance sensing (ECIS). By applying alternating current
and measuring the voltage across an electrode, the impedance can be
calculated and broken down into a series resistance and capacitance.
Insulating membranes of spreading cells block and constrain the
current flow, resulting in measured variations in the impedance. We
showed the applicability of this system with different cell types and
chip designs (Maercker et al. in Eng Life Sci 8: 1–8, 2008). Mesen-
chymal stem cells (MSCs), isolated from bone marrow, were
transferred to a specialized multi-well live cell chip with integrated
electrodes which allowed us to measure cellular interactions by ECIS.
The attachment of MSCs was tested after in vitro induction of dif-
ferentiation into bone or fat tissue. Within 24 h, we were now able to
distinguish different differentiation stages, which also were visualized
by light microscopy in parallel. Specific impedance profiles already
were visible within the first two hours after starting growth in dif-
ferentiation medium. In a ‘‘wound healing assay’’ in the live cell
chips, adipogenic cells showed a reduced migration activity compared
to non-differentiated MSCs. With HaCaT keratinocytes, we tested
cell attachment on the level of gene expression. After induction
(TetOn system) of the expression of nidogen, a protein critical for
extracellular matrix formation, cells showed stronger adhesion than
without nidogen expression, which was documented by characteristic
impedance spectra. Compatible RNAi silencing experiments are
under way. With our measurements we are able to discriminate
between cell types, cell densities, and differentiation status. It even is
possible to describe the function of single adhesion molecules.
Therefore, this noninvasive cell-based assay most probably not only
will help us to improve biological resources for advanced cell ther-
apies. Simulation of the homing process of stem cells in an in vitro
assay also is a promising setup for large-scale gain-of-function or
loss-of-function screenings in functional genomics.
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